- Home
- SLS vs CPHC Comparison
SLS vs CPHC Comparison
Compare SLS & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- CPHC
- Stock Information
- Founded
- SLS 2012
- CPHC 1994
- Country
- SLS United States
- CPHC United States
- Employees
- SLS N/A
- CPHC N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- CPHC Services-Misc. Amusement & Recreation
- Sector
- SLS Health Care
- CPHC Consumer Discretionary
- Exchange
- SLS Nasdaq
- CPHC Nasdaq
- Market Cap
- SLS 89.6M
- CPHC 85.7M
- IPO Year
- SLS N/A
- CPHC 1994
- Fundamental
- Price
- SLS $1.40
- CPHC $17.69
- Analyst Decision
- SLS
- CPHC
- Analyst Count
- SLS 0
- CPHC 0
- Target Price
- SLS N/A
- CPHC N/A
- AVG Volume (30 Days)
- SLS 1.3M
- CPHC 1.5K
- Earning Date
- SLS 05-13-2025
- CPHC 05-08-2025
- Dividend Yield
- SLS N/A
- CPHC 1.59%
- EPS Growth
- SLS N/A
- CPHC N/A
- EPS
- SLS N/A
- CPHC 0.42
- Revenue
- SLS N/A
- CPHC $61,562,288.00
- Revenue This Year
- SLS N/A
- CPHC N/A
- Revenue Next Year
- SLS N/A
- CPHC N/A
- P/E Ratio
- SLS N/A
- CPHC $41.69
- Revenue Growth
- SLS N/A
- CPHC 0.20
- 52 Week Low
- SLS $0.77
- CPHC $16.91
- 52 Week High
- SLS $1.84
- CPHC $24.43
- Technical
- Relative Strength Index (RSI)
- SLS 72.02
- CPHC 44.45
- Support Level
- SLS $1.29
- CPHC $16.91
- Resistance Level
- SLS $1.38
- CPHC $17.30
- Average True Range (ATR)
- SLS 0.09
- CPHC 0.15
- MACD
- SLS 0.03
- CPHC 0.09
- Stochastic Oscillator
- SLS 86.54
- CPHC 84.78
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.